Last Posted: Apr 20, 2017
Genetic risk variants as therapeutic targets for Crohn's disease.
Gabbani Tommaso et al. Expert opinion on therapeutic targets 2017 Apr 21(4) 381-390
Personalized Medicine of Alcohol Addiction: Pharmacogenomics and beyond.
Manolopoulos Vangelis George et al. Current pharmaceutical biotechnology 2017 Feb
Health Disparities and Triple-Negative Breast Cancer in African American Women: A Review.
Newman Lisa A et al. JAMA surgery 2017 Mar
After the epigenome: The epitranscriptome
Science Magazine, March 22, 2017
DNA methylation signatures in peripheral blood strongly predict all-cause mortality
Y Zhang et al, Nature Communications, March 17, 2017
The cancer epigenome: Concepts, challenges, and therapeutic opportunities
MA Dawson et al, Science, March 16, 2017
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.